M
Michael J. Fine
Researcher at University of Pittsburgh
Publications - 294
Citations - 35302
Michael J. Fine is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Community-acquired pneumonia & Pneumonia. The author has an hindex of 84, co-authored 285 publications receiving 32890 citations. Previous affiliations of Michael J. Fine include Veterans Health Administration & University of Lausanne.
Papers
More filters
Journal Article
Heparin in the initial treatment of venous thrombosis. comments. authors' reply
G. A. Corey,Michael J. Fine,Barbara H. Hanusa,Amy L. Phelps,R. Stone,W. N. Rapoor,P. L. Cimo,R. D. Hull,G. E. Raskob +8 more
Journal ArticleDOI
Racial/Ethnic Differences in 30-Day Mortality for Heart Failure and Pneumonia in the Veterans Health Administration Using Claims-based, Clinical, and Social Risk-adjustment Variables.
Gabriella C. Silva,Lan Jiang,Roee Gutman,Wen-Chih Wu,Vincent Mor,Vincent Mor,Michael J. Fine,Nancy R. Kressin,Nancy R. Kressin,Amal N. Trivedi,Amal N. Trivedi +10 more
TL;DR: In this article, the authors compared mortality for non-Hispanic White (hereafter, "White"), non- Hispanic, and Black, and Hispanic Veterans hospitalized for heart failure (HF) and pneumonia and determine whether observed mortality differences varied according to whether claims-based comorbid conditions and/or clinical variables were included in risk-adjustment models.
Journal Article
Brand-Name Prescription Drug Use Among Veterans Affairs and Medicare Part D Patients With Diabetes
Walid F. Gellad,Julie M. Donohue,Xinhua Zhao,Maria K. Mor,Carolyn T. Thorpe,Jeremy M. Smith,Chester B. Good,Michael J. Fine,Nancy E. Morden +8 more
TL;DR: In this article, the use of generic instead of brand-name drugs could reduce health care costs in the U.S. Department of Veterans Affairs and Medicare Part-D programs.
Increased Costs of Diabetes Therapy Not Related to Glycemic Control at Three Veterans Affairs Medical Outpatient Clinics
TL;DR: The primary care provider type and the intensity of treatment were associated with monthly medication costs, monthly total costs, and glycemic control; however, the costs of monthly medications and the total costs were not associated with improved gly glucose control.